兆科眼科-B（ZHAOKE OPHTH-B）近日宣布，已签署一项重要协议。该协议旨在中国内地（不含香港、澳门及台湾地区）推进盐酸依匹斯汀滴眼液的商业化进程。此举标志着这家眼科制药企业，在深耕中国市场的道路上又迈出了关键一步。
兆科眼科-B（ZHAOKE OPHTH-B）近日宣布，已签署一项重要协议。该协议旨在中国内地（不含香港、澳门及台湾地区）推进盐酸依匹斯汀滴眼液的商业化进程。此举标志着这家眼科制药企业，在深耕中国市场的道路上又迈出了关键一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.